At Inato, our mission is to bring clinical research to each and every patient, regardless of who they are and where they live. We are building the world's first clinical trial marketplace to create greater visibility, access, and engagement across a more diverse population of doctors and their patients.
By enabling all community sites to offer the right trials to their patients, we will not only make clinical research more inclusive, but also more efficient.
We have already worked with leading companies on over 50 major global clinical studies and are poised for growth with our recent 14 million USD Series A financing.
Drug development is a challenging, intellectually complex, and rewarding endeavor: we support sponsors and researchers to develop effective treatments for diseases affecting millions more efficiently.
By enabling all community sites to offer the right trials to their patients, we will not only make clinical research more inclusive, but also more efficient.
We have already worked with leading companies on over 50 major global clinical studies and are poised for growth with our recent 14 million USD Series A financing.
Drug development is a challenging, intellectually complex, and rewarding endeavor: we support sponsors and researchers to develop effective treatments for diseases affecting millions more efficiently.
Location: France, Ile-de-France
Employees: 11-50
Phone: +63 939 611 8874
Total raised: $35.53M
Founded date: 2016
Investors 2
| Date | Name | Website |
| - | Cathay Cap... | cathaycapi... |
| - | Fly Ventur... | fly.vc |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 02.04.2023 | - | $20M | - |
| 04.02.2020 | Series A | $14M | Fly Ventur... |
| 15.11.2017 | - | $1.53M | - |
Mentions in press and media 22
| Date | Title | Description |
| 15.09.2025 | Inato Unveils AI Capabilities to Transform Clinical Trial Site Selection | What You Should Know: – Today, Inato unveiled new AI capabilities to enhance and accelerate site selection. Sponsors can now use Inato’s platform to create and execute data-driven site selection scenarios based on real-time interest and ver... |
| 27.05.2025 | Cathay Innovation: $1 Billion VC Fund Closed | Cathay Innovation announced today the final close of its latest venture capital fund at $1 billion, making it the largest AI-focused fund in the European Union. The closing of this fund marks a significant shift in AI-era venture capital, w... |
| 28.01.2025 | Inato Launches AI-Powered Patient Pre-Screening to Reduce Site Burden and Accelerate Enrollment | What You Should Know: – Inato, the leading platform for clinical trial access and inclusivity, today unveiled new capabilities to help research sites efficiently pre-screen patients for trial opportunities. – The company’s latest advancemen... |
| 31.12.2024 | Executives forecast AI's place in healthcare in 2025, part one | Photo: Nicolas Hansen/Getty Images Executives highlighted AI's transformative potential in healthcare when asked by MobiHealthNews how they see AI's place in the sector changing in 2025. Some expect multimodal AI and advanced diagnostic ima... |
| 31.05.2023 | Free Tech for Research Sites to be Showcased in Upcoming Webinar | VersaTrial, Veeva, Slope and Inato Team Up to Present No-Cost Solutions Built for Sites This webinar serves as a platform to introduce tools that are designed from a site-first perspective, immediately deployable, and free of cost.” — Naor ... |
| 12.04.2023 | See the 16-slide presentation a startup used to sell investors on a new approach to solving a $50 billion problem for Big Pharma | Inato's founding team, from left: Bastien Duret, chief technical officer; Kourosh Davarpanah, CEO; Liz Beatty, chief strategy officer; and Raphaelle Mourey, chief customer officer. Inato This story is available exclusively to Insider subscr... |
| 02.04.2023 | Inato Snags $20M to Make Clinical Trials More Diverse & Accessible | Almost three-quarters of all clinical trials are run by the same 5% of academic sites, according to Inato CEO Kourosh Davarpanah. “This lack of patient access causes trial delays and costs to skyrocket, ultimately constraining medical innov... |
| 30.03.2023 | Inato raises $20 million to make clinical trials more efficient and inclusive | Parisian startup Inato has raised $20 million for its AI-based data collection tool for the pharmaceutical sector from return and lead investor Cathay Innovation, return investor Obvious Ventures, and new investors La Maison and Top Harvest... |
| 29.03.2023 | Inato Raises $20M in Series A2 Funding | Inato, a Paris, France-based technology platform enabling access to inclusive clinical trials, closed $20m Series A2 funding. Backers included return and lead investor Cathay Innovation, return investor Obvious Ventures, as well as new inve... |
| 29.03.2023 | Inato Raises $20M to Make Clinical Trials More Inclusive | What You Should Know: – Inato, a technology platform that connects pharma companies (trial sponsors) with community-based trial sites raises $20M in new funding (A2) led by Cathay Innovation with participation from existing investor Obvious... |
Show more